Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation

Kumi Oshima, Yoshinobu Kanda, Yasuhito Nanya, Masatsugu Tanaka, Chiaki Nakaseko, Shingo Yano, Shin Fujisawa, Hiroyuki Fujita, Akira Yokota, Satoshi Takahashi, Heiwa Kanamori, Shinichiro Okamoto

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

While renal comorbidity is generally defined by the serum creatinine level, the creatinine clearance rate (Ccr) is a more accurate indicator of renal function. Therefore, we retrospectively assessed how mildly reduced renal function as defined based on Ccr affects the outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Patients who underwent allogeneic HSCT at the eight institutes of the Kanto Study Group for Cell Therapy were included in this study. Based on the corrected Ccr, patients were classified into group 0 (n = 440, ≥ 90 mL/min/1.73 m2), group 1 (n = 56, 60-89 mL/min/1.73 m2), or group 2 (n = 11, 30-59 mL/min/1.73 m2). Therefore, 67 patients were considered to have mild renal impairment, whereas only 2 had a serum creatinine level higher than 1.2 mg/dL. Twenty-eight patients required hemodialysis after HSCT, with 5.5, 5.4, and 9.1 % in groups 0, 1, and 2, respectively (p = 0.65). The incidence of non-relapse mortality (NRM) was higher in group 2, although these differences were not statistically significant probably due to the small sample size (23.7, 28.2, and 47.2 % at 3 years, p = 0.20). In conclusion, NRM may be associated with mildly reduced renal function before allogeneic HSCT, which cannot be detected by measurement of the serum creatinine level alone.

Original languageEnglish
Pages (from-to)255-260
Number of pages6
JournalAnnals of Hematology
Volume92
Issue number2
DOIs
Publication statusPublished - 2013 Jan

Fingerprint

Hematopoietic Stem Cell Transplantation
Creatinine
Transplantation
Kidney
Serum
Mortality
Group Psychotherapy
Cell- and Tissue-Based Therapy
Sample Size
Renal Dialysis
Comorbidity
Incidence

Keywords

  • Chronic kidney disease
  • HSCT
  • Reduced renal function

ASJC Scopus subject areas

  • Hematology

Cite this

Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation. / Oshima, Kumi; Kanda, Yoshinobu; Nanya, Yasuhito; Tanaka, Masatsugu; Nakaseko, Chiaki; Yano, Shingo; Fujisawa, Shin; Fujita, Hiroyuki; Yokota, Akira; Takahashi, Satoshi; Kanamori, Heiwa; Okamoto, Shinichiro.

In: Annals of Hematology, Vol. 92, No. 2, 01.2013, p. 255-260.

Research output: Contribution to journalArticle

Oshima, K, Kanda, Y, Nanya, Y, Tanaka, M, Nakaseko, C, Yano, S, Fujisawa, S, Fujita, H, Yokota, A, Takahashi, S, Kanamori, H & Okamoto, S 2013, 'Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation', Annals of Hematology, vol. 92, no. 2, pp. 255-260. https://doi.org/10.1007/s00277-012-1584-1
Oshima, Kumi ; Kanda, Yoshinobu ; Nanya, Yasuhito ; Tanaka, Masatsugu ; Nakaseko, Chiaki ; Yano, Shingo ; Fujisawa, Shin ; Fujita, Hiroyuki ; Yokota, Akira ; Takahashi, Satoshi ; Kanamori, Heiwa ; Okamoto, Shinichiro. / Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation. In: Annals of Hematology. 2013 ; Vol. 92, No. 2. pp. 255-260.
@article{bf6da0a316e948bfbf60705ac949d939,
title = "Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation",
abstract = "While renal comorbidity is generally defined by the serum creatinine level, the creatinine clearance rate (Ccr) is a more accurate indicator of renal function. Therefore, we retrospectively assessed how mildly reduced renal function as defined based on Ccr affects the outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Patients who underwent allogeneic HSCT at the eight institutes of the Kanto Study Group for Cell Therapy were included in this study. Based on the corrected Ccr, patients were classified into group 0 (n = 440, ≥ 90 mL/min/1.73 m2), group 1 (n = 56, 60-89 mL/min/1.73 m2), or group 2 (n = 11, 30-59 mL/min/1.73 m2). Therefore, 67 patients were considered to have mild renal impairment, whereas only 2 had a serum creatinine level higher than 1.2 mg/dL. Twenty-eight patients required hemodialysis after HSCT, with 5.5, 5.4, and 9.1 {\%} in groups 0, 1, and 2, respectively (p = 0.65). The incidence of non-relapse mortality (NRM) was higher in group 2, although these differences were not statistically significant probably due to the small sample size (23.7, 28.2, and 47.2 {\%} at 3 years, p = 0.20). In conclusion, NRM may be associated with mildly reduced renal function before allogeneic HSCT, which cannot be detected by measurement of the serum creatinine level alone.",
keywords = "Chronic kidney disease, HSCT, Reduced renal function",
author = "Kumi Oshima and Yoshinobu Kanda and Yasuhito Nanya and Masatsugu Tanaka and Chiaki Nakaseko and Shingo Yano and Shin Fujisawa and Hiroyuki Fujita and Akira Yokota and Satoshi Takahashi and Heiwa Kanamori and Shinichiro Okamoto",
year = "2013",
month = "1",
doi = "10.1007/s00277-012-1584-1",
language = "English",
volume = "92",
pages = "255--260",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation

AU - Oshima, Kumi

AU - Kanda, Yoshinobu

AU - Nanya, Yasuhito

AU - Tanaka, Masatsugu

AU - Nakaseko, Chiaki

AU - Yano, Shingo

AU - Fujisawa, Shin

AU - Fujita, Hiroyuki

AU - Yokota, Akira

AU - Takahashi, Satoshi

AU - Kanamori, Heiwa

AU - Okamoto, Shinichiro

PY - 2013/1

Y1 - 2013/1

N2 - While renal comorbidity is generally defined by the serum creatinine level, the creatinine clearance rate (Ccr) is a more accurate indicator of renal function. Therefore, we retrospectively assessed how mildly reduced renal function as defined based on Ccr affects the outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Patients who underwent allogeneic HSCT at the eight institutes of the Kanto Study Group for Cell Therapy were included in this study. Based on the corrected Ccr, patients were classified into group 0 (n = 440, ≥ 90 mL/min/1.73 m2), group 1 (n = 56, 60-89 mL/min/1.73 m2), or group 2 (n = 11, 30-59 mL/min/1.73 m2). Therefore, 67 patients were considered to have mild renal impairment, whereas only 2 had a serum creatinine level higher than 1.2 mg/dL. Twenty-eight patients required hemodialysis after HSCT, with 5.5, 5.4, and 9.1 % in groups 0, 1, and 2, respectively (p = 0.65). The incidence of non-relapse mortality (NRM) was higher in group 2, although these differences were not statistically significant probably due to the small sample size (23.7, 28.2, and 47.2 % at 3 years, p = 0.20). In conclusion, NRM may be associated with mildly reduced renal function before allogeneic HSCT, which cannot be detected by measurement of the serum creatinine level alone.

AB - While renal comorbidity is generally defined by the serum creatinine level, the creatinine clearance rate (Ccr) is a more accurate indicator of renal function. Therefore, we retrospectively assessed how mildly reduced renal function as defined based on Ccr affects the outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Patients who underwent allogeneic HSCT at the eight institutes of the Kanto Study Group for Cell Therapy were included in this study. Based on the corrected Ccr, patients were classified into group 0 (n = 440, ≥ 90 mL/min/1.73 m2), group 1 (n = 56, 60-89 mL/min/1.73 m2), or group 2 (n = 11, 30-59 mL/min/1.73 m2). Therefore, 67 patients were considered to have mild renal impairment, whereas only 2 had a serum creatinine level higher than 1.2 mg/dL. Twenty-eight patients required hemodialysis after HSCT, with 5.5, 5.4, and 9.1 % in groups 0, 1, and 2, respectively (p = 0.65). The incidence of non-relapse mortality (NRM) was higher in group 2, although these differences were not statistically significant probably due to the small sample size (23.7, 28.2, and 47.2 % at 3 years, p = 0.20). In conclusion, NRM may be associated with mildly reduced renal function before allogeneic HSCT, which cannot be detected by measurement of the serum creatinine level alone.

KW - Chronic kidney disease

KW - HSCT

KW - Reduced renal function

UR - http://www.scopus.com/inward/record.url?scp=84872285910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872285910&partnerID=8YFLogxK

U2 - 10.1007/s00277-012-1584-1

DO - 10.1007/s00277-012-1584-1

M3 - Article

C2 - 23053182

AN - SCOPUS:84872285910

VL - 92

SP - 255

EP - 260

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 2

ER -